logo
ENTITY

IN8bio (INAB US)

6
Analysis
Health Care • United States
IN8bio, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. IN8bio serves customers in the United States.
more
Company Event • 15 Mar 2025 04:00 • Upcoming
Add To Calendar

Q4 2024

Company Event • 13 Nov 2024 05:00 • Upcoming
Add To Calendar

Q3 2024

Company Event • 09 Aug 2024 04:00 • Upcoming
Add To Calendar

Q2 2024

Company Event • 10 May 2024 04:00 • Upcoming
Add To Calendar

Q1 2024

Company Event • 14 Mar 2024 22:00 • Upcoming
Add To Calendar

Q4 2023

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x